'Milk City' plans to distribute milk at rates which are almost Rs 7-10 a litre less than the current prices.
It does not bar any state or the Centre from continuing or launching other food-based schemes.
If it gets the USFDA nod, the sales would help to pull the company out of the red.
Many say trend could lead to concerns on manufacturing quality in Indian facilities.
Through messages via the BSNL network, the ministry plans to spread awareness among the public and ask people not to invest in suspicious companies.
National Pharmaceutical Pricing Authority names Cipla, Dr Reddy's Labs and Ranbaxy among those.
Major hospital chains such as Max Healthcare, Apollo and Fortis are going online in a big way, to extend their operations into smaller towns and cities.
Not far back, in 2010, SRL Diagnostics, promoted by former Ranbaxy promoters Malvinder and Shivinder Singh, acquired the diagnostic services business of Piramal Healthcare for Rs 600 crore (Rs 6 billion).
Department of Pharmaceuticals asks NPPA to review Eli Lilly product prices.
On Monday, the Appellate Board upheld the compulsory licence granted to domestic firm Natco Pharma last year, against Bayer's patented anti-cancer drug Nexavar.
The panel of representatives from various ministries and chaired by B K Singh, director, department of pharmaceuticals, has suggested the government negotiate prices of patented medicines based on reference prices of such drugs in other countries such as Britain, Canada, France, Australia and New Zealand.
While the office of the Drugs Controller General of India is still struggling to accumulate data, compensation had been paid only in 50 per cent of the clinical trial death cases so far, sources said.
Companies run till now by mostly their promoters are increasingly inducting professionals to head their teams.
Charge relates to misuse of dominant position to sell spare parts at high rates.
No ethics committee shall review and accord its approval to a clinical trial protocol without prior registration with the licensing authority, as defined in clause (b) of rule 21.
FM may announce a credit guarantee fund for Farmer Producer Organisations.
Disappointed with past experience, domestic majors even skip giving any memorandum.
Increase in Budgetary allocation likely to be only 5.8%, the lowest in six years
Regulator mentions Wockhardt as manufacturer but firm says it only markets drug.
The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances